Change in the psychosocial status of type 2 diabetes mellitus patients losing weight (a pilot study)

DOI: https://doi.org/10.29296/25877305-2020-07-11
Download full text PDF
Issue: 
7
Year: 
2020

I. Pashkova; I. Gatskikh, Candidate of Medical Sciences; T. Potupchik, Candidate of Medical
Sciences; T. Shalda; A. Galaktionov; I. Obednina Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical
University

The authors have evaluated the psychosocial status of patients with type 2 diabetes mellitus (T2DM) during weight loss with the use of Reduxin Met. The data obtained from the SF-36 questionnaires suggest that weight loss in men and women positively affects the individual components of both their mental and physical health. Reduxin Met as a component of combination therapy for T2DM can be recommended for weight loss.
Keywords: 
endocrinology
obesity
diabetes mellitus
psychosocial status
Reduxin Met

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Ametov A.S., Prudnikova M.A. Rol' preparatov dlja snizhenija massy tela v poetapnom upravlenii saharnym diabetom tipa 2: fokus na sibutramin. Endokrinologija: Novosti. Mnenija. Obuchenie. 2017; 1: 52–9 [Ametov A.S., Prudnikova M.A. The Role of drugs for weight loss in the phased management of diabetes mellitus type 2: focus on sibutramine. Endocrinology: News. Opinions. Training. 2017; 1: 52–9 (in Russ.)].
  2. Amirdzhanova V.N., Gorjachev D.V., Korshunov N.I. i dr. Populjatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (Rezul'taty mnogotsentrovogo issledovanija kachestva zhizni «Mirazh»). Nauchno-prakticheskaja revmatologija. 2008; 1: 36–48 [Amirdzhanova V.N., Goryachev D.V., Korshunov N.I. et al. Population indicators of quality of life according to SF-36 questionnaire (Results of multicenter study of quality of life «Mirage»). Scientific and practical rheumatology. 2008; 1: 36–48 (in Russ.)].
  3. Burkov S.G., Ivleva A.Ja. Izbytochnyj ves i ozhirenie – problema meditsinskaja, a ne kosmeticheskaja. Ozhirenie i metabolizm. 2010; 3: 15 [Burkov S.G., Ivleva A.Y. Overweight and obesity – a medical problem, not a cosmetic one. Obesity and metabolism. 2010; 3: 15 (in Russ.)].
  4. Gosudarstvennyj reestr lekarstvennyh sredstv [Gosudarstvennyi reestr lekarstvennykh sredstv (in Russ.)]. Rezhim dostupa / Available at: https://grls.rosminzdrav.ru/grls.aspx
  5. Ionova T.I., Novik A.A. Rukovodstvo po issledovaniju kachestva zhizni v meditsine. Pod red. Ju.L. Shevchenko. 2-e izd. M.: OLMAPRESS, 2007 [Ionova T.I., Novik A.A. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. Pod red. Yu.L. Shevchenko. 2-e izd. M.: OLMAPRESS, 2007 (in Russ)].
  6. Lipchina O.I. Korrektsija metabolicheskih narushenij i pischevogo povedenija u patsientov s ozhireniem na fone priema kombinatsii preparatov Reduksin® (sibutramin+MKTs) i metformin v ramkah Vserossijskoj nabljudatel'noj programmy «PrimaVera». Endokrinologija: Novosti. Mnenija. Obuchenie. 2015; 2: 447 [Lipchina O.I. Correction of metabolic disorders and eating behavior in patients with obesity on the background of receiving a combination of drugs reducsin (sibutramine+MCC) and Metformin in the framework of the all-Russian observation program «Primavera». Endocrinology: News. Opinions. Training. 2015; 2: 44–7 (in Russ)].
  7. Romantsova T.I. Epidemija ozhirenija: ochevidnye i verojatnye prichiny. Ozhirenie i metabolizm. 2011; 1: 5–17 [Romantsova T.I. obesity Epidemic: obvious and probable causes. Obesity and metabolism. 2011; 1: 5–17 (in Russ.)].
  8. Samojlova Ju.G., Rotkank M.A., Zhukova N.G. i dr. Variabel'nost' glikemii u patsientov s saharnym diabetom 1-go tipa: svjaz' s kognitivnoj disfunktsiej i dannymi magnitno-rezonansnyh metodov issledovanija. Problemy endokrinologii. 2018; 64 (5): 286–91 [Samoilova I.G., Rotkank M.A., Zhukova N.G. et al. Variability of glycemia in patients with type 1 diabetes mellitus: the relationship with cognitive dysfunction and the results of magnetic resonance imaging. Problems of endocrinology (archive until 2020). 2018; 64 (5): 286–91. (in Russ.)]. https://doi.org/10.14341/probl9589
  9. Shostak N.A., Klimenko A.A., Shemenkovoj V.S. i dr. Ispol'zovanie oprosnika SF-36 v otsenke kachestva zhizni u patsientov s hronicheskoj tromboembolicheskoj legochnoj gipertenziej. Klinitsist. 2017; 3–4: 44–9 [Shostak N.A., Klimenko A.A., Shemenkova V.S. et al. the use of the SF-36 questionnaire in assessing the quality of life in patients with chronic thromboembolic pulmonary hypertension. Clinician. 2017; 3–4: 44–9 (in Russ.)]. DOI: 10.17650/1818-8338-2017-11-3-4-44-49
  10. Erdes Sh., Erdes K.Sh. Voprosnik SF-36 i ispol'zovanie ego pri revmatoidnom artrite. Nauchno-prakticheskaja revmatologija. 2003; 2: 47–52 [Erdes S., Erdes K.S. SF-36 And its use in rheumatoid arthritis. Scientific and practical rheumatology. 2003; 2: 47–52 (in Russ.)].
  11. 36-Item Short Form Survey (SF-36). URL: https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html